$557 Million is the total value of Davide Leone & Partners Investment Co Ltd.'s 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 400.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AABA | Buy | ALTABA INC | $106,092,000 | -63.7% | 5,446,180 | +29.4% | 19.05% | -19.0% |
| S | New | SPRINT CORPORATION | $38,690,000 | – | 6,270,634 | +100.0% | 6.95% | – |
| BIIB | New | BIOGEN INC | $32,387,000 | – | 139,107 | +100.0% | 5.82% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $12,970,000 | – | 76,558 | +100.0% | 2.33% | – |
| New | AVAYA HLDGS CORPnote 2.250% 6/1 | $1,542,000 | – | 1,800,000 | +100.0% | 0.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 19 | Q3 2023 | 7.8% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q4 2021 | 14.1% |
| BLACKBERRY LTD | 9 | Q4 2021 | 10.1% |
| ILLUMINA INC | 8 | Q4 2020 | 8.8% |
| ENCOMPASS HEALTH CORP | 7 | Q2 2022 | 98.2% |
| INCYTE CORP | 6 | Q1 2021 | 5.0% |
| AMERICAN WELL CORP | 6 | Q4 2021 | 2.7% |
| BIOMARIN PHARMACEUTICAL INC | 5 | Q3 2021 | 9.1% |
| VONTIER CORPORATION | 5 | Q4 2021 | 9.9% |
| QIAGEN NV | 5 | Q1 2021 | 7.7% |
View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Davide Leone & Partners Investment Co Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.